12. 12. 2024
Understanding cancer on a molecular and cellular level is a challenge that has direct effects on the development of new drugs or new diagnostic and therapeutical methods. Plasmonic affinity biosensors are in this context an important technology for detection of biomolecules and study of their interactions. Compared to traditional methods, these new optical platforms enable a fast analysis of samples with minimal preparation. Markéta Bocková, from the Optical Biosensors Research Group at the Institute of Photonics and Electronics of the CAS, part of the National Institute for Cancer Research, presents the use of optical biosensors in cancer research.
16. 10. 2024
In the strategy of NICR, they were looking for a subject that would meet the parameters of both novelty and excellence. Václav Liška, head of the Laboratory of cancer treatment and tissue regeneration, which is active at the Faculty of Medicine of CU in Pilsen, was for these reasons attracted to rare tumours.
22. 8. 2024
Let’s beat cancer by understanding cellular architecture! That is the motto of the new, fully internationally staffed research group of the NICR. It was created in the Prague node of the NICR at the Institute of Biochemistry and Experimental Oncology of the First Faculty of Medicine of the Charles University.
12. 6. 2024
The newly created research group of Zdeněk Andrysík investigates the molecular mechanisms of tumours, with focus on the use of modulation of transcription factors’ activity in targeted oncological treatments. The group was created in the Brno node of NICR at the Institute of Biology (Faculty of Medicine, Masaryk University).
27. 3. 2024
In 2023, a new research group focused on virology and molecular carcinogenesis was set up in the Node Olomouc of NICR in the Institute of Molecular and Translational Medicine of Palacký University, Olomouc. Its head, Vladimíra Koudeláková, allowed us to take a peek into its multidisciplinary ‘kitchen’.